The Disease-Risk Stratification Scheme (DRSS), a contemporary risk-stratification system for allogeneic stem cell transplantation Meeting Abstract


Authors: Shouval, R.; Fein, J. A.; Labopin, M.; Bazarbachi, A.; Baron, F.; Bug, G.; Ciceri, F.; Corbacioglu, S.; Giebel, S.; Gilleece, M. H.; Montoto, S.; Peric, Z.; Polge, E.; Ruggeri, A.; Sanz, J.; Savani, B. N.; Schmid, C.; Spyridonidis, A.; Versluis, J.; Yakoub-Agha, I.; Mohty, M.; Nagler, A.
Abstract Title: The Disease-Risk Stratification Scheme (DRSS), a contemporary risk-stratification system for allogeneic stem cell transplantation
Meeting Title: 61st Annual Meeting of the American Society of Hematology (ASH)
Abstract: DISCLOSURES: Labopin: Jazz Pharmaceuticals: Honoraria. Bug:Pfizer: Membership on an entity's Board of Directors or advisory committees; Jazz Pharmaceuticals: Honoraria; Hexal: Membership on an entity's Board of Directors or advisory committees; Gilead Sciences: Membership on an entity's Board of Directors or advisory committees, Other: Travel grants; Celgene: Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: travel grants; Sanofi: Other: travel grants; Novartis: Membership on an entity's Board of Directors or advisory committees, Research Funding; Celgene Neovii: Other: travel grant. Mohty:Jazz Pharmaceuticals: Honoraria, Research Funding. © 2019 by The American Society of Hematology.
Journal Title: Blood
Volume: 134
Issue: Suppl. 1
Meeting Dates: 2019 Dec 7-10
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2019-11-13
Start Page: 43
Language: English
DOI: 10.1182/blood-2019-123310
PUBMED: 31724016
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus